Skip to main content

Revolutionising the way cartilage tumours are diagnosed and managed with the help of bactip.co.uk

The Musculoskeletal Radiology department at The Royal Orthopaedic Hospital (ROH) has developed bactip.co.uk, a website designed to enhance the diagnosis and management of cartilage tumours.

bactip.co.uk provides healthcare professionals with a user platform that equips them with the tools and knowledge to navigate the complexities of central cartilage tumours. By offering drawings and real case examples this website serves as a valuable resource for interpreting Musculoskeletal Radiology imaging findings related to these tumours, ensuring their accurate and consistent reporting. Developed collaboratively by experts in the field, bactip.co.uk offers an approach for assessing, diagnosing and monitoring these lesions.

A standout feature of bactip.co.uk is its integrated calculator, which streamlines the grading process based on tumour characteristics, like size and aggressiveness. This innovative tool aims to simplify decision making processes for healthcare professionals dealing with cartilage tumours. This advanced tool also standardises the reporting of central cartilage tumours, reducing subjective differences and improving patient care.

bactip.co.uk enables radiologists and clinicians to make informed decisions by offering an imaging follow up plan. Whether it involves suggesting a referral to an oncology specialist or safely discharging a patient from surveillance monitoring, the protocol provides a detailed framework customised for each unique case.

As a leading authority in orthopaedic excellence, the ROH Musculoskeletal Radiology department is proud to share its expertise through bactip.co.uk, an open-source free resource.

Dr A Mark Davies comments: β€œThis initiative reflects our commitment to openness making sure that healthcare professionals worldwide can access our cutting-edge knowledge and best practices without any barriers. Our dedication to spreading knowledge and best practices aligns with our shared goal of enhancing patient outcomes on a global scale.”

Β